Carla Nunes Paulino Borisch

Carla Nunes Paulino Borisch

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2025 in Cells
Verified
Journal Article
Open access
PDF file
AGAnkita Garg
Ankita Garg
MJMalte Juchem
Malte Juchem
SBSinje Biss
Sinje Biss
CBCarla Nunes Paulino Borisch
Carla Nunes Paulino Borisch
JLJulia Leonardy
Julia Leonardy
Thomas ThumThomas Thum
Thomas Thum
Background: A deregulated aldosterone (Aldo)–mineralocorticoid receptor (MR) pathway is linked to cardiovascular disease (CVD), including hypertension and heart failure. Despite the association of elevated plasma Aldo levels with cardiac stress, inflammation, myocardial fibrosis, and cardiac remodeling, the underlying mechanisms remain elusive. Methods: To study the impact of Aldo–MR pathway overactivation on cardiac health, a novel mouse model with AAV9-mediated MR overexpression and Aldo administration via subcutaneous osmotic pumps was generated. Echocardiographic analyses, transcriptome sequencing, and loss-of-function experiments of an identified lead candidate gene were performed. Additionally, cardiac tissue samples from human patients with end-stage heart failure were analyzed in the study. Results: Mice with an overactivated Aldo–MR pathway exhibited increased neutrophil gelatinase-associated lipocalin (NGAL) expression, cardiac dysfunction, hypertrophy, and fibrosis. Transcriptomics identified prostaglandin D2 synthase (Ptgds) as a novel downstream effector of the cardiac Aldo–MR pathway. SiRNA-mediated inhibition of Ptgds in primary cardiomyocytes reduced NGAL levels and the hypertrophic impact of Aldo, suggesting a role in mediating Aldo-induced cardiac pathologies. Elevated expression of PTGDS was observed in hiPSC-CMs treated with the pro-hypertrophic cytokine leukemia inhibitory factor (LIF) and in end-stage heart failure patients, ascertaining its importance in cardiac disease settings. Conclusions: PTGDS is a newly identified mediator of Aldo–MR-induced cardiac remodeling and may represent a potential therapeutic target for CVD.

26 June 2026 in Genome Biology and Evolution
Verified
Journal Article
Open access
SKSven Künzel
Sven Künzel
CBCarla Nunes Paulino Borisch
Carla Nunes Paulino Borisch
CBCornelia Burghardt
Cornelia Burghardt
CHCorinna Heidinger
Corinna Heidinger
DTDiethard Tautz
Diethard Tautz
De novo gene emergence from non-coding sequences is an important evolutionary mechanism, yet the functional potential of random sequences remains debated. Previous experiments suggested that expression of random sequence clones in Escherichia coli can enhance growth of cells, i.e. they can provide a direct fitness advantage. However, these findings have been questioned, regarding potential confounding effects of the clone mixtures and a possibly negatively acting peptide expressed from the cloning vector. Here we performed controlled competitive growth assays using a defined subset of random sequence clones representing a spectrum of fitness effects. Experiments across multiple conditions, including two different growth cycle durations, induction states, and replicate sets, showed high technical reproducibility and consistent clone-specific growth trajectories for the majority of the clones, but for some also influences of genomic background and experimental conditions. While previous results for vector-derived control constructs could be confirmed, several random sequence clones exhibited higher positive selection coefficients then these vector constructs. These relative effects persisted even when negative clones were excluded, indicating that they are not driven by competition dynamics with negative clones. Our results demonstrate that positive growth effects of random sequence clones cannot be explained by clone mixture and vector artifacts alone. Instead, a subset of random sequences confers genuine fitness advantages comparable to beneficial mutations observed in experimental evolution studies. These findings provide experimental support for the capacity of random sequences to directly generate adaptive effects without the necessity to acquire additional adaptive mutations.

17 August 2026 in Stem Cell Research
Verified
Journal Article
Open access
NHNick Heise
Nick Heise
CBCarla Nunes Paulino Borisch
Carla Nunes Paulino Borisch
CJChristopher Jahn
Christopher Jahn
KSKristina Sonnenschein
Kristina Sonnenschein
NDNataliya Di Donato
Nataliya Di Donato
MJMalte Juchem
Malte Juchem
Fabry disease (FD) is a monogenic, X-linked lysosomal storage disorder originating from mutations in the GLA gene, which encodes alpha-galactosidase A. Impaired enzyme activity leads to accumulation of the substrate globotriaosylceramide (Gb3) and a multisystemic phenotype. Here, we generated two human induced pluripotent stem cell (hiPSC) lines from a female FD patient carrying a heterozygous c.644A > G missense mutation. The hiPSCs displayed normal karyotype, typical morphology, trilineage differentiation capacity and expressed markers of undifferentiated hPSC state. Consequently, MHHi043-A and MHHi043-B provide a valuable resource for studying FD mechanisms and developing therapeutic strategies.